Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

American HomePatient Reports Financial Results for the First Quarter of 2001 and Announces an Agreement in Principal With Its Lender Group.


Business Editors

BRENTWOOD Brentwood, city and district, England
Brentwood, city (1991 pop. 51,212) and district, Essex, SE England. Brentwood is mainly residential but produces some agricultural equipment, film, and prefabricated concrete.
, Tenn.--(BUSINESS WIRE)--May 16, 2001

American American, river, 30 mi (48 km) long, rising in N central Calif. in the Sierra Nevada and flowing SW into the Sacramento River at Sacramento. The discovery of gold at Sutter's Mill (see Sutter, John Augustus) along the river in 1848 led to the California gold rush of  HomePatient, Inc. (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
:AHOM) today reported its financial results for the three months ended March 31, 2001. Earnings before interest, taxes, depreciation and amortization Earnings before interest, taxes, depreciation and amortization (EBITDA) is a non-GAAP metric that can be used to evaluate a company's profitability.
:EBITDA = Operating Revenue – Operating Expenses + Other Revenue
 (EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) A metric used to show a company's profitability, but not its cash flow. EBITDA became popular in the 1980s to show the potential profitability of leveraged buyouts, but has become ) for the quarter was $12.0 million, representing an increase of $2.8 million over the same quarter of 2000. The Company's net loss for the first quarter of 2001 was $(6.6) million compared to $(8.6) million for the first quarter of 2000.

Revenue for the three months ended March 31, 2001 was $91.1 million, up from $87.9 million reported for the same three-month period of 2000, representing an increase of $3.2 million. The revenue increase over the prior-year quarter is the result of internal growth of approximately 3% along with the consolidation of several of the Company's joint ventures beginning in the second quarter of 2000, offset by lost revenue associated with the termination of a contract effective January January: see month.  2001.

EBITDA margin for the first three months of 2001 was 13.2% of net revenue compared to 10.5% for the first three months of 2000. Overall, operating expenses Operating expenses

The amount paid for asset maintenance or the cost of doing business, excluding depreciation. Earnings are distributed after operating expenses are deducted.
 decreased in the current three-month period compared to last year. This decrease is due primarily to a significant improvement in bad debt expense. As a percentage of revenue, bad debt expense in the first quarter of 2001 was 4.3% compared to 7.8% in the first quarter of 2000. This improvement in bad debt expense is largely the result of improved cash collections resulting from the redesign re·de·sign  
tr.v. re·de·signed, re·de·sign·ing, re·de·signs
To make a revision in the appearance or function of.



re
 and standardization standardization

In industry, the development and application of standards that make it possible to manufacture a large volume of interchangeable parts. Standardization may focus on engineering standards, such as properties of materials, fits and tolerances, and drafting
 of reimbursement Reimbursement

Payment made to someone for out-of-pocket expenses has incurred.
 processes and the consolidation of certain billing locations into larger regional billing centers.

The Company and its lender group also announced today that they have reached an agreement in principal to amend the Company's current credit agreement. As previously reported, the Company is in default under its credit facility as a result of breaching several financial covenants and failing to make a principal payment due March 15, 2001. The amended a·mend  
v. a·mend·ed, a·mend·ing, a·mends

v.tr.
1. To change for the better; improve: amended the earlier proposal so as to make it more comprehensive.

2.
 credit agreement is expected to cure the current defaults, amend the principal amortization schedule, and extend the term of the agreement to December December: see month.  31, 2002. The Company expects to finalize fi·nal·ize  
tr.v. fi·nal·ized, fi·nal·iz·ing, fi·nal·iz·es
To put into final form; complete or conclude: "They have jointly agreed ...
 the amendment on or about May 18, 2001.

American HomePatient is one of the nation's largest home health care providers with over 300 centers in 38 states. Its product and service offerings include respiratory services, infusion INFUSION, med. jur. A pharmaceutical operation, which consists in pouring a hot or cold fluid upon a substance, whose medical properties it is desired to extract. Infusion is also used for the product of this operation. Although infusion differs from decoction, (q.v.  therapy, parenteral parenteral /pa·ren·ter·al/ (pah-ren´ter-al) not through the alimentary canal, but rather by injection through some other route, as subcutaneous, intramuscular, etc.

par·en·ter·al
adj.
1.
 and enteral nutrition Enteral nutrition
Nourishment given through a tube or stoma directly into the small intestine, thus bypassing the upper digestive tract.

Mentioned in: Electrolyte Supplements, Enterostomy, Necrotizing Enterocolitis

, and medical equipment for patients in their home. American HomePatient's common stock is currently traded over-the-counter under the symbol AHOM.

Certain statements made in the press release may constitute forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Such forward-looking statements are based on management's current expectations and include known and unknown risks, uncertainties and other factors, many of which the company is unable to predict or control, that may cause the company's actual results or performance to materially differ from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks, uncertainties and other factors detailed from time to time in the company's filings with the Securities and Exchange Commission. Such factors may include the increased cost of borrowing under the company's credit agreement, changes to the company's business strategy and operation, the effect of healthcare legislation and regulation, the ability to obtain business, the outcome of ongoing governmental investigations, and the success in or timing of finalizing an amended credit agreement with its lenders. The company cautions investors that any forward-looking statements made by the company are not necessarily indicative of future performance.


American HomePatient
Summary Financial Data
(In thousands, except per share data)

                                                  Three Months Ended
                                                        Mar. 31,
                                                  -------------------
                                                    2001       2000
                                                  -------------------

Revenues                                          $ 91,121   $ 87,890

Cost of sales and related services                  22,170     21,826

Operating expenses                                  52,966     53,464

General and administrative expenses                  3,938      3,350

Depreciation and amortization                        8,515     10,211

Earnings (loss) before interest and taxes            3,532       (961)

Pre-tax loss                                        (6,447)    (8,424)

Net loss                                          $ (6,597)  $ (8,574)


Basic loss per share                              $  (0.40)  $  (0.55)
Diluted loss per share                            $  (0.40)  $  (0.55)

Weighted average shares outstanding - Basic         16,352     15,480
Weighted average shares outstanding - Diluted       16,352     15,480


                                                  Mar. 31,   Dec. 31,
                                                    2001       2000
                                                  --------   --------
Cash & Equivalents                                $ 15,107   $ 12,081
Restricted Cash                                          6        179
Net Patient Receivables                             72,381     74,498
Other Receivables                                      854        967
                                                  --------   --------
        Total Receivables                           73,235     75,465
Other Current Assets                                15,574     17,011
                                                  --------   --------
        Total Current Assets                       103,922    104,736
Property and Equipment, Net                         51,230     52,998
Goodwill                                           196,072    197,491
Other Assets                                        23,339     23,289
                                                  --------   --------
        Total Assets                              $374,563   $378,514
                                                  ========   ========

Accounts Payable                                  $ 15,691   $ 16,449
Current Portion of Long Term Debt                  297,775    297,787
Other Current Liabilities                           34,196     30,937
                                                  --------   --------
        Total Current Liabilities                  347,662    345,173
Long Term Debt, less current portion                 1,294      1,365
Other Liabilities                                    5,763      5,737
                                                  --------   --------
        Total Liabilities                          354,719    352,275
        Total Stockholders' Equity                  19,844     26,239
                                                  --------   --------
        Total Liabilities and Equity              $374,563   $378,514
                                                  ========   ========
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:May 16, 2001
Words:848
Previous Article:MontaVista Supports IBM PowerNP NP4GS3 Network Processor with Hard Hat Linux.
Next Article:ADC Selects HSS and Kshema for Strategic Alliance in India.
Topics:



Related Articles
American HomePatient, Inc. Files Extension for Reporting Fiscal 1998.
American HomePatient Notifies Banks of Noncompliance.
American HomePatient Continues Negotiations With Lenders and Does Not Make Scheduled Principal Payment.
American HomePatient Reports Financial Results for the Fourth Quarter and 12 Months Ended December 31, 2000; Company to File Notice of Late Form 10-K...
American HomePatient, Inc. Files Form 10-K for the Twelve Months Ended December 31, 2000.
American HomePatient Amends Its Credit Facility With Its Lender Group and Will File Amended Annual and Quarterly Reports.
American HomePatient Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2001.
American HomePatient Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2001.
American HomePatient Reports Financial Results for the First Quarter Ended March 31, 2002.
American HomePatient Reports 2002 Financial Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles